Alex Zhavoronkov, PhD at NextMed Health March 14 (IMAGE)
InSilico Medicine
Caption
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, is a pioneer in generative AI for drug discovery.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.